These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23692343)

  • 1. Activity of dexrazoxane and amifostine against late cardiotoxicity induced by the combination of doxorubicin and cyclophosphamide in vivo.
    Bjelogrlic SK; Lukic ST; Djuricic SM
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):228-38. PubMed ID: 23692343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo.
    Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
    Herman EH; Zhang J; Chadwick DP; Ferrans VJ
    Cancer Chemother Pharmacol; 2000; 45(4):329-34. PubMed ID: 10755322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.
    Asselin BL; Devidas M; Chen L; Franco VI; Pullen J; Borowitz MJ; Hutchison RE; Ravindranath Y; Armenian SH; Camitta BM; Lipshultz SE
    J Clin Oncol; 2016 Mar; 34(8):854-62. PubMed ID: 26700126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.
    Smith TA; Phyu SM; Akabuogu EU
    Anticancer Res; 2016 Jan; 36(1):87-93. PubMed ID: 26722031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
    Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Walker UA
    Br J Pharmacol; 2007 Jul; 151(6):771-8. PubMed ID: 17519947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice.
    Liu L; Shi R; Shi Q; Cheng Y; Huo Y
    Planta Med; 2008 Feb; 74(3):203-9. PubMed ID: 18260050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice.
    Bjelogrlic SK; Radic J; Jovic V; Radulovic S
    Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):311-9. PubMed ID: 16236144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer].
    Gershanovich ML; Moiceenko VM; Orlova RV
    Vopr Onkol; 1993; 39(1-3):26-32. PubMed ID: 8073671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal-averaged electrocardiography in survivors of Hodgkin's disease treated with and without dexrazoxane.
    Mladosievicova B; Foltinová A; Petrásová H; Bernadic M; Hulín I
    Neoplasma; 2001; 48(1):61-5. PubMed ID: 11327539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.
    QuanJun Y; GenJin Y; LiLi W; YongLong H; Yan H; Jie L; JinLu H; Jin L; Run G; Cheng G
    PLoS One; 2017; 12(1):e0169567. PubMed ID: 28072830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice.
    Vijay V; Moland CL; Han T; Fuscoe JC; Lee T; Herman EH; Jenkins GR; Lewis SM; Cummings CA; Gao Y; Cao Z; Yu LR; Desai VG
    Toxicol Appl Pharmacol; 2016 Mar; 295():68-84. PubMed ID: 26873546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats.
    Jahnukainen K; Jahnukainen T; Salmi TT; Svechnikov K; Eksborg S; Söder O
    Cancer Res; 2001 Sep; 61(17):6423-7. PubMed ID: 11522636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiopharmaceutical model using 99mTc-MIBI to evaluate amifostine protection against doxorubicin cardiotoxicity in rats.
    Yurekli Y; Unak P; Ertay T; Biber Z; Medine I; Teksoz S
    Ann Nucl Med; 2005 May; 19(3):197-200. PubMed ID: 15981672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway.
    Pei XM; Yung BY; Yip SP; Ying M; Benzie IF; Siu PM
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E311-23. PubMed ID: 24326424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B].
    Hu KY; Yang Y; He LH; Wang DW; Jia ZR; Li SR; Tian W; Mao J; Li XJ; Zhang W
    Yao Xue Xue Bao; 2014 Jul; 49(7):1007-12. PubMed ID: 25233631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
    Lipshultz SE; Rifai N; Dalton VM; Levy DE; Silverman LB; Lipsitz SR; Colan SD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE
    N Engl J Med; 2004 Jul; 351(2):145-53. PubMed ID: 15247354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines.
    Pouillart P
    Cancer Treat Rev; 2004 Nov; 30(7):643-50. PubMed ID: 15531396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane.
    Lenčová-Popelová O; Jirkovský E; Jansová H; Jirkovská-Vávrová A; Vostatková-Tichotová L; Mazurová Y; Adamcová M; Chládek J; Hroch M; Pokorná Z; Geršl V; Šimůnek T; Štěrba M
    J Mol Cell Cardiol; 2016 Feb; 91():92-103. PubMed ID: 26724189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study.
    Rigatos SK; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
    Anticancer Res; 2002; 22(1A):129-34. PubMed ID: 12017274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.